Skip to main content
Comparing r1 → r1.a1−48bytes
Article Changes2 modified · 28 unchanged
=== Harm Reduction === === Forms & Identification === 3-MeO-PCMo circulates only as a [[glossary:synthetic]] powder from unregulated [[glossary:novel-psychoactive-substance|research chemical]] vendors. No [[glossary:pharmaceutical-grade|pharmaceutical-grade]] formulation exists — purity and identity cannot be assumed from appearance. [[glossary:positional-isomer|Positional isomers]] in the PCMo series (2-MeO, 3-MeO, 4-MeO) are visually indistinguishable and chemically near-identical{{cite|doi=10.1002/dta.2213|anchor=4a670a57}}. [[glossary:reagent-kit|Reagent tests]] confirm the [[substance_class:chemical/arylcyclohexylamine]] class but cannot reliably distinguish between [[glossary:isomer|isomers]]. A drug-checking service is the only reliable way to verify identity and rule out more potent [[glossary:contamination|contaminants]]. === Set & Setting === The 1–2 hour onset creates a specific risk: prepare the environment fully before dosing. Once effects manifest, the ability to adjust surroundings or relocate is compromised. A calm, familiar, low-[[effect:stimulation]] environment reduces the risk of [[glossary:disorientation]] and [[effect:anxiety]]. [[substance_class:psychoactive/dissociative]] states amplify environmental input unpredictably. A sober companion who understands the compound's long onset is valuable, especially at higher doses where [[effect:delusions-of-sobriety]] may impair self-assessment. {{Guideline}} === Guidelines === * Test all material with a reagent kit and, where available, a drug-checking service before use. * Start with a low dose and wait a minimum of 2.5 hours before considering any [[glossary:redose]] — the slow onset is the most common [[glossary:trigger]] for accidental [[glossary:overdose]] through premature redosing. * Pre-measure the dose with a milligram-precision scale. Do not estimate by eye. * Eat a light meal 2–3 hours before dosing to reduce [[effect:nausea]] without slowing [[glossary:absorption]] unpredictably. * Remove access to vehicles, sharp objects, and balconies before onset. * Have a sober [[glossary:sitter]] present, especially for unfamiliar doses. * Keep water accessible. Avoid [[substance:alcohol]] entirely. * Set a phone timer at dosing to track elapsed time — time [[glossary:perception]] is unreliable under dissociation. {{/Guideline}} {{Emergency}} === Emergency Response === '''Recognizing an emergency:''' Uncomfortable but manageable effects (nausea, [[effect:confusion]], anxiety) are distinct from medical emergencies. Seek immediate help if any of the following occur: slow or stopped breathing, blue or grey lips, unresponsiveness to voice and touch, [[glossary:seizure]], severe [[glossary:chest-pain]], or [[glossary:body-temperature]] that feels dangerously hot or cold through clothing. '''Immediate steps:''' * 1. Call emergency services immediately. * 2. Place the person on their side in the [[glossary:recovery-position]] if they are unconscious but breathing. * 3. Do not leave them alone. * 4. Do not induce [[effect:vomiting]]. * 5. Do not physically restrain them unless they pose immediate danger to themselves or others — agitated dissociation can escalate with restraint. * 6. Monitor breathing continuously until help arrives. '''What to tell the dispatcher:''' State what substance was taken, how much, when it was taken, and what symptoms you observe. [[glossary:good-samaritan-law|Good Samaritan laws]] in many jurisdictions protect people who call for help during a [[glossary:drug-emergency]] from [[glossary:prosecution]]. No specific reversal agent exists for 3-MeO-PCMo. All treatment is supportive. {{/Emergency}} {{Aftercare}} === Aftercare & Integration === Dissociative [[glossary:aftereffect|aftereffects]] may persist for 12–24 hours after the primary experience resolves. Residual cognitive fog, emotional flatness, or mild [[effect:derealization]] are common and typically self-limiting. Prioritize sleep, [[glossary:hydration]], and light nutrition in the hours following the experience. Avoid driving or operating machinery until cognitive function feels fully restored. If the experience was intense or distressing, talking it through with a trusted person can help process unusual perceptual states. Persistent derealization, anxiety, or mood changes lasting more than a few days warrant professional evaluation. {{/Aftercare}} {{Recovery}} === Recovery & Support === For individuals who find themselves using 3-MeO-PCMo or other dissociatives compulsively, professional support is available. Dissociative [[glossary:dependence]] often develops gradually — escalating frequency and dose may not feel problematic until functional [[glossary:impairment]] becomes apparent. SAMHSA's National Helpline (1-800-662-4357) provides free, confidential [[glossary:referral|referrals]]. Online communities and [[index:harm-reduction|harm reduction]] organizations can offer [[glossary:peer-support]] and practical guidance for reducing or stopping use. {{/Recovery}}
=== Harm Reduction === === Forms & Identification === 3-MeO-PCMo circulates exclusively as a [[glossary:synthetic]] powder from unregulated [[glossary:novel-psychoactive-substance|research chemical]] vendors. No [[glossary:pharmaceutical-grade|pharmaceutical-grade]] formulation exists, meaning purity and identity cannot be assumed from appearance alone. [[glossary:positional-isomer|Positional isomers]] in the PCMo series (2-MeO, 3-MeO, 4-MeO) are chemically near-identical and visually indistinguishable{{cite|doi=10.1002/dta.2213|anchor=46627c5e}}. [[glossary:reagent-kit|Reagent testing]] can confirm the [[substance_class:chemical/arylcyclohexylamine]] class but cannot reliably distinguish between these [[glossary:isomer|isomers]]. Quantitative analysis through a drug-checking service is the only reliable method to verify identity and rule out more potent [[glossary:contamination|contaminants]]. === Set & Setting === The 1–2 hour onset window creates a distinct risk profile. Prepare the environment fully before dosing — once effects manifest, the ability to adjust surroundings or relocate is compromised. A calm, familiar, low-[[effect:stimulation]] environment is strongly recommended. [[substance_class:psychoactive/dissociative]] states amplify environmental input unpredictably: quiet settings tend toward serenity, while chaotic or unfamiliar ones can produce [[glossary:disorientation]] and [[effect:anxiety]]. A sober companion who understands the compound's long onset and duration is valuable, particularly at higher doses where [[effect:delusions-of-sobriety]] may impair self-assessment. {{Guideline}} === Guidelines === * Test all material with a reagent kit and, where available, a drug-checking service before use. * Start with a low dose and wait a minimum of 2.5 hours before considering any [[glossary:redose]] — the slow onset is the most common [[glossary:trigger]] for accidental [[glossary:overdose]] through premature redosing. * Pre-measure the dose with a milligram-precision scale. Do not estimate by eye. * Eat a light meal 2–3 hours before dosing to reduce [[effect:nausea]] without slowing [[glossary:absorption]] unpredictably. * Remove access to vehicles, sharp objects, and balconies before onset. * Have a sober [[glossary:sitter]] present, especially for unfamiliar doses. * Keep water accessible. Avoid [[substance:alcohol]] entirely. * Set a phone timer at dosing to track elapsed time — time [[glossary:perception]] is unreliable under dissociation. {{/Guideline}} {{Emergency}} === Emergency Response === '''Recognizing an emergency:''' Uncomfortable but manageable effects (nausea, [[effect:confusion]], anxiety) are distinct from medical emergencies. Seek immediate help if any of the following occur: slow or stopped breathing, blue or grey lips, unresponsiveness to voice and touch, [[glossary:seizure]], severe [[glossary:chest-pain]], or [[glossary:body-temperature]] that feels dangerously hot or cold through clothing. '''Immediate steps:''' * 1. Call emergency services immediately. * 2. Place the person on their side in the [[glossary:recovery-position]] if they are unconscious but breathing. * 3. Do not leave them alone. * 4. Do not induce [[effect:vomiting]]. * 5. Do not physically restrain them unless they pose immediate danger to themselves or others — agitated dissociation can escalate with restraint. * 6. Monitor breathing continuously until help arrives. '''What to tell the dispatcher:''' State what substance was taken, how much, when it was taken, and what symptoms you observe. [[glossary:good-samaritan-law|Good Samaritan laws]] in many jurisdictions protect people who call for help during a [[glossary:drug-emergency]] from [[glossary:prosecution]]. No specific reversal agent exists for 3-MeO-PCMo. All treatment is supportive. {{/Emergency}} {{Aftercare}} === Aftercare & Integration === Dissociative [[glossary:aftereffect|aftereffects]] may persist for 12–24 hours after the primary experience resolves. Residual cognitive fog, emotional flatness, or mild [[effect:derealization]] are common and typically self-limiting. Prioritize sleep, [[glossary:hydration]], and light nutrition in the hours following the experience. Avoid driving or operating machinery until cognitive function feels fully restored. If the experience was intense or distressing, talking it through with a trusted person can help process unusual perceptual states. Persistent derealization, anxiety, or mood changes lasting more than a few days warrant professional evaluation. {{/Aftercare}} {{Recovery}} === Recovery & Support === For individuals who find themselves using 3-MeO-PCMo or other dissociatives compulsively, professional support is available. Dissociative [[glossary:dependence]] often develops gradually — escalating frequency and dose may not feel problematic until functional [[glossary:impairment]] becomes apparent. SAMHSA's National Helpline (1-800-662-4357) provides free, confidential [[glossary:referral|referrals]]. Online communities and [[index:harm-reduction|harm reduction]] organizations can offer [[glossary:peer-support]] and practical guidance for reducing or stopping use. {{/Recovery}}
Evidence Changes1 added · 1 removed
+DEA 2026— Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine in Schedule I (Final Rule)
−2026— Federal Register: Placement of 3-Methoxyphencyclidine in Schedule I (2026)